Article
Author(s):
Top news of the day from across the healthcare landscape.
A ruling from Judge Rosemary M. Collyer that stopped reimbursement for insurers under the Affordable Care Act could cause significant increases in health insurance premiums for millions of people. If these insurers are not reimbursed, the cost of these high premiums could be passed on to the government, taxpayers, administration officials, and health policy experts, according to The New York Times.
Pfizer announced its plans to acquire Anacor Pharmaceuticals for $5.2 billion about a month after terminating its merger with Allergan. Pfizer has now been trying to acquire smaller, American biotechnology companies and split their company in half. The New York Times reports that Pfizer will have brand name products on one side of their company and generic products on the other.
Valeant Pharmaceuticals International Inc said that it would offer discounts of at least 10%, but the drugs can be reduced by up to 40% based on how much volume is bought. The Patient Access and Pricing Committee established by Valeant said there would be no further price increases or cuts to discounts. The committment was created after the company came under fire for its dramatic price increases, according to The Wall Street Journal.
2 Commerce Drive
Cranbury, NJ 08512